VA3

General Information


DRACP ID  DRACP03526

Peptide Name   VA3

Sequence  KWXWKXAKXAK

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiparasitic; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C52H74N14O6

Absent amino acids  CDEFGHILMNPQRSTVY

Common amino acids  K

Mass  149980

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  4

Net charge  4

Boman Index  -1392

Hydrophobicity  -125.45

Aliphatic Index  18.18

Half Life 
  /

Extinction Coefficient cystines  11000

Absorbance 280nm  1100

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23876294

Title  Mechanism of action of novel Synthetic peptide dodecapeptides against Candida albicans

Doi Not available

Year  2013

Literature 2

Pubmed ID 22118799

Title  In vitro antibacterial and antimalarial activity of dehydrophenylalanine-containing undecapeptides alone and in combination with drugs

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6284

DRACP is developed by Dr.Zheng's team.